← FDA Drug Approvals (Drugs@FDA)
HALOPERIDOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2024-01-31
Drug application
- FDA Application #
ANDA218371- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HALOPERIDOL
- Generic name
- HALOPERIDOL
- Active ingredients
- HALOPERIDOL LACTATE
- Dosage form
- CONCENTRATE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Advagen Pharma Ltd
- First approval
- 2024-01-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown